Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Champions Oncology, Inc. CSBR NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
$5.13
-10.5%
Analyst Price Target
$12.00
+109.4%

Champions Oncology, Inc. (CSBR) has 12 identified peers for comparison in the Healthcare sector. Peers include ACRV, ADAG, ANEB, ANTX, AVTE, CYT and others.

CSBR has a market capitalization of $79.57M, compared to an average peer market cap of $115.97M.

People Also View

ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
 RZLT
RZLT
Rezolute, Inc.
$3.56
-1.36%
 STTK
STTK
Shattuck Labs, Inc.
$6.78
+0.15%
 IPSC
IPSC
Century Therapeutics, Inc.
$2.37
+4.41%
 MOLN
MOLN
Molecular Partners AG
$4.14
-1.66%
 ADAG
ADAG
Adagene Inc.
$3.81
-0.78%
 PRDS
PRDS
Pardes Biosciences, Inc.
$2.18
+0.93%
 CYT
CYT
Cyteir Therapeutics, Inc.
$3.02
-2.27%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message